Evidence that factors other than 1,25 dihydroxyvitamin D may play a role in augmenting intestinal calcium absorption in patients with primary hyperparathyroidism
- PMID: 3085897
- DOI: 10.1007/BF02556710
Evidence that factors other than 1,25 dihydroxyvitamin D may play a role in augmenting intestinal calcium absorption in patients with primary hyperparathyroidism
Abstract
We examined 17 patients with primary hyperparathyroidism for their serum 1,25 dihydroxyvitamin D levels and for their fractional intestinal calcium absorption rates using a whole body counter and calcium-47. As controls, 10 normal volunteers were examined both before and after administration of 1 alpha-hydroxyvitamin D to increase serum 1,25 dihydroxyvitamin D. Values of serum 1,25 dihydroxyvitamin D were 71.6 +/- 37.6 pg/ml (mean +/- SD) in patients with primary hyperparathyroidism and 75.3 +/- 27.7 pg/ml (mean +/- SD) in normal volunteers after administration of 1 alpha-hydroxyvitamin D, while values of intestinal calcium absorption rate were 61.5 +/- 16.5% (mean +/- SD) in patients with primary hyperparathyroidism and 34.1 +/- 5.1% (mean +/- SD) in normal controls, respectively. There was a positive correlation between values of serum 1,25 dihydroxyvitamin D and intestinal calcium absorption in both groups. However, in patients with primary hyperparathyroidism, intestinal calcium absorption was more increased than that in normal volunteers when compared to their serum values of 1,25 dihydroxyvitamin D. This suggests that another factor than 1,25 dihydroxyvitamin D plays an important role in the intestinal calcium absorption in patients with primary hyperparathyroidism.
Similar articles
-
New insights on the pathogenesis of hypercalcemia in primary hyperparathyroidism.Am J Med Sci. 2000 Nov;320(5):334-6. doi: 10.1097/00000441-200011000-00007. Am J Med Sci. 2000. PMID: 11093687
-
Effect of parathyroidectomy on serum 1 alpha,25-dihydroxyvitamin D and intestinal calcium absorption in primary hyperparathyroidism.J Clin Endocrinol Metab. 1979 May;48(5):877-9. doi: 10.1210/jcem-48-5-877. J Clin Endocrinol Metab. 1979. PMID: 429532
-
Vitamin D analogues for the management of secondary hyperparathyroidism.Am J Kidney Dis. 2001 Nov;38(5 Suppl 5):S34-40. doi: 10.1053/ajkd.2001.28109. Am J Kidney Dis. 2001. PMID: 11689385 Review.
-
Comparison of intestinal calcium absorption and circulating 1,25-dihydroxyvitamin D levels in malignancy-associated hypercalcaemia and primary hyperparathyroidism.Clin Endocrinol (Oxf). 1987 Mar;26(3):281-91. doi: 10.1111/j.1365-2265.1987.tb00785.x. Clin Endocrinol (Oxf). 1987. PMID: 3652475
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
References
MeSH terms
Substances
LinkOut - more resources
Research Materials